Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABIGAIL: Abemaciclib + ET vs Paclitaxel in 1L HR+/HER2- Advanced Breast Cancer
NCT04603183Phase 2Completed
- Sponsor
- MEDSIR
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of abemaciclib in breast cancer, sponsored by MEDSIR. Started Jun 2021; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04603183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603183.